| Theodore Tzavaras, | |
|
600 Gresham Dr, Suite 304, Norfolk, VA 23507 | |
| (757) 388-3397 | |
| Not Available |
| Full Name | Theodore Tzavaras |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 600 Gresham Dr, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093109001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101264359 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Of Tidewater | 5092618462 | 150 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life.
As domestic violence skyrockets amid COVID-19, women's health experts are calling for compulsory training of obstetric health practitioners to ensure they can recognise the signs of coercive control for women in their care.
› Verified 7 days ago
| Entity Name | Emergency Physicians Of Tidewater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033136841 PECOS PAC ID: 5092618462 Enrollment ID: O20040202000195 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life.
As domestic violence skyrockets amid COVID-19, women's health experts are calling for compulsory training of obstetric health practitioners to ensure they can recognise the signs of coercive control for women in their care.
› Verified 7 days ago
| Entity Name | Observation Physicians Of Tidewater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306590450 PECOS PAC ID: 8123401429 Enrollment ID: O20220819000428 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life.
As domestic violence skyrockets amid COVID-19, women's health experts are calling for compulsory training of obstetric health practitioners to ensure they can recognise the signs of coercive control for women in their care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theodore Tzavaras, 600 Gresham Dr, Suite 304, Norfolk, VA 23507-1904 Ph: (757) 388-3397 | Theodore Tzavaras, 600 Gresham Dr, Suite 304, Norfolk, VA 23507 Ph: (757) 388-3397 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis, which University of Florida Health researchers say significantly impact their quality of life.
As domestic violence skyrockets amid COVID-19, women's health experts are calling for compulsory training of obstetric health practitioners to ensure they can recognise the signs of coercive control for women in their care.
› Verified 7 days ago
Ruth Gordon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6379 Center Dr, Norfolk, VA 23502 Phone: 757-467-4200 | |
Miss Kaci Elizabeth Gogel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Rm 304, Emergency Department, Norfolk, VA 23507 Phone: 757-388-3397 Fax: 757-388-2885 | |
Dr. Benjamin Lee Chidester, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Gresham Drive, Norfolk, VA 23507 Phone: 757-388-3000 | |
Dr. Moses Tucker Laffitte Iv, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Gresham Drive, Norfolk, VA 23507 Phone: 757-388-3000 | |
Dr. Clay Kingsley Lifton, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Raleigh Building Room 304, Norfolk, VA 23507 Phone: 757-388-3397 | |
Rosemary Guerguerian, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7007 Fax: 757-668-8658 |